鞍钢股份(00347.HK)与鞍钢北京研究院订立2020年技术开发协议
鞍钢股份(00347.HK)公布关连交易,与鞍钢北京研究院订立2020年技术开发协议,以为公司合作研发若干技术。
公司指,鞍钢北京研究院是鞍钢集团公司下属的具有前瞻性的技术研发平台,具有较高的科研定位,在钢铁材料技术研究、新材料计算设计、工艺模拟技术等领域具有较强的科研实力。上述项目研发成功将有助於提升公司基础研发水平,使公司保持目前造船用钢等领域的领先水平,拓展自身在新能源汽车、耐蚀降噪铁基阻尼合金以及针状焦粉制备锂电矽碳负极材料等新材料领域的引领能力,从而为公司提升科技研发能力、产品竞争力和未来盈利能力提供强有力支撑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.